Evaxion Expands Vaccine Development Collaboration with MSD
Evaxion Biotech A/S announced that it has entered into an option and license agreement with MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) for two preclinical vaccine candidates. The agreement expands the companies’ current collaboration and …